glp-1 and alcoholism Medscape | Once weekly semaglutide injections reduced alcohol consumption in patients with alcohol use disorder comorbid obesity. Results of the GLP-1s Hold Promise as Treatment

Recalls & Warnings August 01, 2022 53 Protein, Meal Replacement and Nutritional Beverages Recalled Due to Bacterial Contamination On July 29, 2022, Lyons Magnus LLC issued a recall of 53 protein, meal replacement, and nutritional beverages, including those sold under the brand names of Glucerna, Premier Protein, Oatly, and others, due to the potential for microbial contamination, including from Cronobacter sakazakii

Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients

How Does Sofwave Support Collagen Remodeling

Alpha-synuclein locus duplication as a cause of familial Parkinsons disease